Recent Quotes

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-20
REV		(EXPECTED)2021-08-20

Q1 2021		Est.		Actual		Surprise
EPS		-0.710		-0.470		0.2400
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
OCUP	Ocuphire Pharma	4.98	0.08	1.63%		77.9M

Ocuphire Pharma Frequently Asked Questions

How do I buy Ocuphire Pharma (OCUP) stock?

You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.

View our list of the best stock brokerages.

Who are Ocuphire Pharma's (OCUP) competitors?

Other companies in Ocuphire Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Opiant Pharmaceuticals (NASDAQ:OPNT), Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).

What is the target price for Ocuphire Pharma (OCUP) stock?

The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Alliance Global Partners on April 5, 2021. The analyst firm set a price target for 25.00 expecting OCUP to rise to within 12 months (a possible 402.01% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Ocuphire Pharma (OCUP)?

The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $4.98 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Does Ocuphire Pharma (OCUP) pay a dividend?

There are no upcoming dividends for Ocuphire Pharma.

When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?

Ocuphire Pharma’s Q2 earnings are confirmed for after-market on August 20, 2021.

Is Ocuphire Pharma (OCUP) going to split?

There is no upcoming split for Ocuphire Pharma.

What sector and industry does Ocuphire Pharma (OCUP) operate in?

Ocuphire Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.